EU Optimal Blood Use Project
  • French
  • Portugese
  • German
  • Polish
  • Italian
  • Spanish
  • Greek
 
  • Synopsis
  • Purpose
  • Quality System
  • Adverse events
  • Documentation
  • Blood components
  • Clinical
  • Blood Bank
  • Audit
  • Training
  • Resources
  • Clinical
    • Quality of clinical evidence
    • Epidemiology of blood use
    • Which patients get transfused?
    • To transfuse or not?
    • Urgent and emergency transfusion – major bleeding
    • Clinical conditions that require a clinical transfusion guideline
    • Evidence: Systematic reviews and clinical guidelines
    • Evidence-based recommendations for practice
    • Key points about the clinical indications for transfusing blood components
    • Platelets
    • Fresh Frozen Plasma
    • Fibrinogen replacement
    • Frequently asked questions about blood components
    • Avoiding the need to transfuse: planned surgery
    • Informing patients
  • Home
  • Clinical
  • Fibrinogen replacement
Print page
Email page

Fibrinogen replacement

In many EU countries, a fibrinogen product made by plasma fractionation is used for fibrinogen replacement in dysfibrinogenaemia and acquired hypofibrinogenaemia seen in massive transfusion and DIC. An alternative is cryoprecipitate.

Top
 
  • © EU Optimal Blood Use Project 2012
  • Contact us
  • Help
  • Links
  • Site Map
  • Data Protection
  • This site is funded by TMREF, Edinburgh